[1]孙春阳,赵长海.全腹腔镜胃部分离断后胃肠吻合术治疗老年胃癌合并幽门梗阻的远期疗效[J].医学信息官方网站,2022,35(15):91-94.[doi:10.3969/j.issn.1006-1959.2022.15.020]
　SUN Chun-yang,Zhao Chang-hai.Long-term Efficacy of Total Laparoscopic Gastroenteric Anastomosis After Partial Gastrectomy in the Treatment of Elderly Gastric Cancer Complicated with Pyloric Obstruction[J].Medical Information,2022,35(15):91-94.[doi:10.3969/j.issn.1006-1959.2022.15.020]
点击复制

全腹腔镜胃部分离断后胃肠吻合术治疗老年胃癌合并幽门梗阻的远期疗效()
分享到：

《医学信息》官方网站[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年15期
页码:
91-94
栏目:
论著
出版日期:
2022-08-01

文章信息/Info

Title:
Long-term Efficacy of Total Laparoscopic Gastroenteric Anastomosis After Partial Gastrectomy in the Treatment of Elderly Gastric Cancer Complicated with Pyloric Obstruction
文章编号:
1006-1959（2022）15-0091-04
作者:
孙春阳; 赵长海
（佳木斯市中心医院普外科，黑龙江 佳木斯 154000）
Author(s):
SUN Chun-yang; Zhao Chang-hai
(Department of General Surgery,Jiamusi Central Hospital,Jiamusi 154000,Heilongjiang,China)
关键词:
全腹腔镜胃部分离断后胃肠吻合术; 胃癌; 幽门梗阻; 老年患者; 远期疗效
Keywords:
Gastrointestinal anastomosis after total laparoscopic partial gastrectomy; Gastric cancer; Pyloric obstruction; Elderly patients; Long-term efficacy
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2022.15.020
文献标志码:
A
摘要:
目的 探究全腹腔镜胃部分离断后胃肠吻合术（TLSPGJ）治疗老年胃癌（GC）合并幽门梗阻（PO）的远期疗效。方法 选择2018年3月-2021年3月佳木斯市中心医院收治的62例老年GC并PO患者为研究对象，采用随机数字表法分为对照组与观察组，各31例。对照组行常规胃空肠吻合术治疗，观察组应用TLSPGJ治疗，比较两组围术期指标[术中出血量、术后视觉模拟评分（VAS）、胃管留置时间、术后首次进食时间、术后住院时间]、手术并发症、生活质量（QLQ-ST022）评分及远期疗效（术后1年生存率、幽门梗阻复发率）。结果 观察组术中出血量、术后VAS评分小于对照组，胃管留置时间、术后首次进食时间、术后住院时间短于对照组，差异有统计学意义（P＜0.05）；观察组手术并发症总发生率低于对照组，差异有统计学意义（P＜0.05）；两组QLQ-ST022评分均低于治疗前，且观察组QLQ-ST022评分低于对照组，差异有统计学意义（P＜0.05）；观察组术后1年生存率高于对照组，幽门梗阻复发率低于对照组，差异有统计学意义（P＜0.05）。结论 TLSPGJ治疗老年GC合并PO效果确切，可减少手术出血，减轻术后疼痛，缩短患者的恢复时间，且并发症少，有助于改善患者生存质量，远期疗效理想。
Abstract:
Objective To investigate the long-term efficacy of total gastrointestinal anastomosis after total laparoscopic partial gastrectomy(TLSPGJ) in the treatment of elderly gastric cancer (GC) complicated with pyloric obstruction (PO).Methods A total of 62 elderly patients with GC and PO who were admitted to Jiamusi Central Hospital from March 2018 to March 2021 were selected as the research objects. They were divided into the control group and the observation group by random number table method, with 31 cases in each group. The control group was treated with conventional gastrojejunostomy, and the observation group was treated with TLSPGJ. The perioperative indexes [intraoperative blood loss, postoperative visual analogue scale (VAS), gastric tube indwelling time, postoperative first feeding time, postoperative hospital stay], surgical complications, quality of life (QLQ-ST022) score and long-term efficacy (1-year survival rate and recurrence rate of pyloric obstruction) were compared between the two groups.Results The intraoperative blood loss and postoperative VAS score in the observation group were less than those in the control group, and the gastric tube retention time, postoperative first feeding time and postoperative hospitalization time were shorter than those in the control group, the difference was statistically significant (P<0.05). The total incidence of surgical complications in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). The QLQ-ST022 scores of the two groups were lower than those before treatment, and the QLQ-ST022 score of the observation group was lower than that of the control group, and the difference was statistically significant (P<0.05). The 1-year survival rate of the observation group was higher than that of the control group, and the recurrence rate of pyloric obstruction was lower than that of the control group (P<0.05).Conclusion TLSPGJ is effective in the treatment of elderly GC combined with PO, which can reduce surgical bleeding, relieve postoperative pain, shorten the recovery time of patients, and has fewer complications, which is helpful to improve the quality of life of patients, and the long-term effect is ideal.

参考文献/References:

[1]蒋天宇,马君俊,臧潞,等.胃空肠转流术联合转化治疗后根治性切除治疗胃癌合并幽门梗阻的临床疗效[J].中华消化外科杂志,2021,20(9):967-973.[2]Wang HH,Angeli TR,Beban G,et al.Slow wave coupling across a gastroduodenal anastomosis as a mechanism for post-surgical gastric dysfunction: evidence for a "Gastric Aberrant Pathway"[J].AJP Gastrointestinal and Liver Physiology,2019,317(2):G141-G146.[3]张震,苏妍卓,李畅,等.胃肠吻合术联合术后化疗治疗不能根治切除伴幽门梗阻的进展期胃癌[J].中国普外基础与临床杂志,2019,26(11):1342-1345.[4]张一帆.全腹腔镜下远端胃切除术联合三角吻合术治疗胃癌的临床研究[J].实用癌症杂志,2021,36(9):1521-1523,1527.[5]Lakshmana R,Sivamarieswaran R,Gopinathan A.A comparative study on the outcome of stapler anastomosis vs. hand-sewn anastomosis in elective gastrointestinal surgeries[J].Journal of Evolution of Medical and Dental Sciences,2018,7(19):2303-2308.[6]刘昊,徐泉,马福海,等.全腹腔镜胃部分离断后胃肠吻合术治疗胃癌合并幽门梗阻的临床效果[J].中华肿瘤杂志,2020,42(6):445-448.[7]中华医学会肿瘤学分会,中华医学会杂志社.中华医学会胃癌临床诊疗指南(2021版)[J].中华医学杂志,2022,102(16):1169-1189.[8]吴楚营,叶凯,许建华,等.改良Overlap吻合与传统辅助切口吻合在腹腔镜全胃根治术中的临床疗效[J].中华消化外科杂志,2020,19(9):988-994.[9]田庆林,李阳,陈晓峰.腹腔镜远端胃癌根治术毕Ⅱ式联合Braun吻合术对胃癌肠道屏障功能血清炎性因子水平的影响[J].河北医学,2020,26(1):41-45.[10]张洪志,任远,张旭,等.胃癌伴幽门梗阻患者的腹腔镜手术价值探讨[J].实用临床医药杂志,2020,24(21):9-11.[11]周典伟,徐建华,胡宁,等.全腹腔镜下单纯毕Ⅱ式及毕Ⅱ式联合Braun吻合治疗远端胃癌的临床比较[J].现代消化及介入诊疗,2019,24(6):618-622.[12]张峰,朱求实,王满贞,等.毕Ⅱ式吻合术联合改良Braun吻合术对腹腔镜远端胃癌切除术患者的临床疗效及安全性[J].癌症进展,2019,17(3):315-317.[13]刘天舟,刘晶晶,乔小放,等.腹腔镜胃部分离断后胃肠吻合术治疗胃出口型梗阻1例报告[J].中国实用外科杂志,2018,38(11):1318-1319,1321.[14]李婷,赵平武.完全腹腔镜胃癌根治术腔内食管空肠侧侧吻合的临床应用研究[J].腹腔镜外科杂志,2018,23(10):761-765.[15]唐滔,叶进军,李德宁,等.全腹腔镜下改良三角吻合技术在胃癌根治术中临床应用[J].中国现代普通外科进展,2018,21(6):441-443,465.[16]景东帅,雷亮亮,张丽柯,等.全腹腔镜胃部分离断后胃肠吻合术对老年胃癌合并幽门梗阻的远期临床疗效分析[J].中国现代普通外科进展,2022,25(4):283-286.[17]杨海涛,匡荣康.全腹腔镜下三角吻合术进行胃癌远端胃切除术消化道重建的安全性和可行性[J].实用癌症杂志,2017,32(10):1738-1740.[18]罗建飞,闫瑞承,赫杰,等.全腹腔镜全胃癌根治术食管右侧近端空肠Roux-en-Y吻合消化道重建的临床应用[J].临床外科杂志,2017,25(10):765-767.[19]甄雄严,宋雪云,张文缙,等.两种术式治疗胃癌合并幽门梗阻的近远期疗效比较[J].实用临床医药杂志,2017,21(15):125-127.[20]仇广林,魏超,朱梦珂,等.早期胃上部癌腹腔镜近端胃切除双通道吻合与腹腔镜全胃切除Roux-en-Y吻合两种消化道重建术式的疗效比较[J].中华胃肠外科杂志,2022,25(5):412-420.

相似文献/References:

[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息官方网站,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
　YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,31(15):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息官方网站,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
　RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,31(15):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息官方网站,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
　DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Medical Information,2018,31(15):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息官方网站,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
　PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Medical Information,2018,31(15):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息官方网站,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
　LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Medical Information,2022,35(15):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[6]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息官方网站,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(15):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[7]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息官方网站,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
　LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Medical Information,2018,31(15):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[8]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息官方网站,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
　MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Medical Information,2018,31(15):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[9]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息官方网站,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
　ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Medical Information,2018,31(15):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[10]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息官方网站,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
　WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,31(15):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]

更新日期/Last Update: 1900-01-01